Log In
Print
BCIQ
Print
Print this Print this
 

Undisclosed plasma-derived product

  Manage Alerts
Collapse Summary General Information
Company ProMetic Life Sciences Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentDiscovery
Standard Indication Hematology (unspecified)
Indication DetailsTreat Type I plasminogen deficiency (hypoplasminogenemia)
Regulatory Designation

U.S. - Orphan Drug (Treat Type I plasminogen deficiency (hypoplasminogenemia))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today